Log In
Print
BCIQ
Print
Print this Print this
 

Ocplex, Pronativ (octaplex)

  Manage Alerts
Collapse Summary General Information
Company Octapharma AG
DescriptionFreeze-dried human prothrombin complex
Molecular Target
Mechanism of ActionReverse anticoagulant
Therapeutic ModalityBiologic
Latest Stage of DevelopmentMarketed
Standard IndicationBleeding
Indication DetailsReversal of anticoagulation therapy in patients receiving vitamin K antagonist therapy in need of urgent surgery or invasive procedure
Regulatory Designation

U.S. - Fast Track (Reversal of anticoagulation therapy in patients receiving vitamin K antagonist therapy in need of urgent surgery or invasive procedure);
U.S. - Orphan Drug (Reversal of anticoagulation therapy in patients receiving vitamin K antagonist therapy in need of urgent surgery or invasive procedure)

Partner

Pfizer Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today